Dietary marine ω-3 fatty acids and incident sight-threatening retinopathy in middle-aged and older individuals with type 2 diabetes: Prospective investigation from the PREDIMED trial

JAMA Ophthalmology

Volumn 134, Issue 10, 2016, Pages 1142-1149

  Sala Vila, Aleix ^a,b   Díaz López, Andrés ^b,c   Valls Pedret, Cinta ^a,b   Cofán, Montserrat ^a,b   García Layana, Alfredo ^d   Lamuela Raventós, Rosa María ^b,e   Castañer, Olga ^b,f   Zanon Moreno, Vicente ^b,g   Martinez Gonzalez, Miguel A ^b,d   Toledo, Estefanía ^b,d   Basora, Josep ^b,c   Salas Salvadó, Jordi ^b,c   Corella, Dolores ^b,g   Gómez Gracia, Enrique ^b,h   Fiol, Miquel ^b,i   Estruch, Ramón ^a,b   Lapetra, José ^b,j   Fitó, Montserrat ^b,f   Arós, Fernando ^b,k   Serra Majem, Luis ^b,l   Pintó, Xavier ^b,m   Ros, Emilio ^a,b   more..

^a HOSPITAL CLÍNIC   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

^h UNIVERSITY OF MÁLAGA   (Spain)

ⁱ HEALTH RESEARCH INSTITUTE OF THE BALEARIC ISLANDS IDISBA   (Spain)

^j San Pablo Health Center   (Spain)

^k University Hospital of Alava   (Spain)

^l UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^m HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID PLUS EICOSAPENTAENOIC ACID; EXTRA VIRGIN OLIVE OIL; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIANGIOGENIC THERAPY; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HAZARD RATIO; HUMAN; INCIDENCE; LASER COAGULATION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEX; VITRECTOMY; CLINICAL TRIAL; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; MULTICENTER STUDY; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SEA FOOD; SPAIN; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEAFOOD; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84997402815     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2016.2906     Document Type: Article

References (25)

1. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650-2664.
2. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17.
3. Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Experiment Ophthalmol. 2016;44(4): 260-277.
4. Semeraro F, Cancarini A, dell'Omo R, Rezzola S, Romano MR, Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res. 2015;2015:582060.
5. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2005;24 (1):87-138.
6. Das UN. Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy. Nutrition. 2013;29(1):1-7.
7. Ma Q, Shen JH, Shen SR, Das UN. Bioactive lipids in pathological retinopathy. Crit Rev Food Sci Nutr. 2014;54(1):1-16.
8. Sapieha P, Chen J, Stahl A, et al. Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr Diabetes. 2012;2:e36.
9. Tikhonenko M, Lydic TA, Opreanu M, et al. N-3 polyunsaturated fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function. PLoS One. 2013;8(1):e55177.
10. Connor KM, SanGiovanni JP, Lofqvist C, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007;13(7):868-873.
11. Yanai R, Mulki L, Hasegawa E, et al. Cytochrome P450-generated metabolites derived from σ-3 fatty acids attenuate neovascularization. Proc Natl Acad Sci U S A. 2014;111(26):9603-9608.
12. Estruch R, Ros E, Salas-Salvadó J, et al; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279-1290.
13. ISSFAL. Intake of PUFA in healthy adults. http://www.issfal.org/statements/pufa-recommendations/statement-3. Accessed January 28, 2015.
14. Kris-Etherton PM, Harris WS, Appel LJ; AHA Nutrition Committee, American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23 (2):151-152.
15. Martínez-González MÁ, Corella D, Salas-Salvadó J, et al; PREDIMED Study Investigators. Cohort profile: design and methods of the PREDIMED study. Int J Epidemiol. 2012;41(2):377-385.
16. Elosua R, Marrugat J, Molina L, Pons S, Pujol E; The MARATHOM Investigators. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. Am J Epidemiol. 1994;139(12):1197-1209.
17. Fernández-Ballart JD, Piñol JL, Zazpe I, et al. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr. 2010; 103(12):1808-1816.
18. Schröder H, Fitó M, Estruch R, et al. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr. 2011;141(6):1140-1145.
19. Bosch J, Gerstein HC, Dagenais GR, et al; ORIGIN Trial Investigators. n-3 Fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012;367(4):309-318.
20. ORIGIN Trial Investigators. Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE). Diabetes Care. 2016;39(5):709-716.
21. Byeon SH, Chu YK. Comment on: Tikhonenko et al. (2010) Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes;59:219-227. Diabetes. 2010;59(7):e11.
22. Sasaki M, Kawasaki R, Rogers S, et al. The associations of dietary intake of polyunsaturated fatty acids with diabetic retinopathy in well-controlled diabetes. Invest Ophthalmol Vis Sci. 2015;56(12):7473-7479.
23. Díaz-López A, Babio N, Martínez-González MA, et al; PREDIMED Study Investigators. Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: a post hoc analysis of a randomized trial. Diabetes Care. 2015; 38(11):2134-2141.
24. Romero-Aroca P, de la Riva-Fernandez S, Valls-Mateu A, Sagarra-Alamo R, Moreno-Ribas A, Soler N. Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population. Br J Ophthalmol. 2016;bjophthalmol-2015-307689.
25. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053.